CD38 and cancer: We hypothesize that tumor microenvironment enriched in the products of CD38 ecto-enzymatic activity may keep healthy HSCs in the quiescent state leading to cancer-related pancytopenia [67] as well as it may preserve the dormancy of cancer stem cells leading to disease persistence.